Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit
Authors:
- Tobias NeffTNTobias Neff
- C.ANthony BlauCBC.ANthony Blau
- 1 March 1999
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (3) , 520-525
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrowBlood, 1996
- Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitorsImmunity, 1995
- The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors.Journal of Experimental Medicine, 1995
- Total marrow failure induced by pegylated stem-cell factor administered before 5-fluorouracilBlood, 1994
- Splenic primitive hematopoietic stem cell (PHSC) activity is enhanced by steel factor because of PHSC proliferationBlood, 1994
- Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAsNature, 1994
- Hematopoietic repopulation of adult mice with beta-thalassemiaBlood, 1994
- Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cellsCell, 1993
- In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cellsBlood, 1993
- A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populationsCell, 1991